NovoCure NVCR Earnings Call Transcripts

NASDAQ NVCR
$11.81 -0.72 (-5.75%)
As of: Nov 10, 2026 · 3:59 PM EST
26 earnings calls on file for NovoCure, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

NovoCure Q3 2026 Earnings Call

Oct 29, 2026 5,606 words · 24 min read
  • William F. DoyleExecutive Chairman
  • Frank LeonardChief Executive Officer
  • Uri WeinbergChief Innovation and Medical Officer
  • Christoph BrackmannChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

NovoCure Earnings Call Transcripts

Calls26
LatestOct 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 26 NovoCure transcripts Register to get access to NovoCure’s earnings call transcripts.